Showing results (141-150 of 829) with videos related to

Sort By:
Pageof 83
Diabetes, Obesity & Metabolism|October 22, 2021
The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trialsEmilie H Zobel, Bernt Johan von Scholten, Tine W Hansen, et al.
Cardiovascular Diabetology|May 21, 2015
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetesBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.
Nephron. Clinical Practice|January 22, 2011
Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathyHenrik Reinhard, Peter Karl Jacobsen, Maria Lajer, et al.
Cardiovascular Diabetology|August 2, 2011
Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuriaHenrik Reinhard, Mads Nybo, Peter R Hansen, et al.
Diabetes, Obesity & Metabolism|July 11, 2018
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular riskNienke M A Idzerda, Frederik Persson, Michelle J Pena, et al.
Diabetes Care|July 27, 2005
Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathySofia B Ahmed, Peter Hovind, Hans-Henrik Parving, et al.
Journal of the American Society of Nephrology : JASN|January 18, 2008
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathyHans-Henrik Parving, Dick de Zeeuw, Mark E Cooper, et al.
Clinical Endocrinology|September 23, 2008
Microalbuminuria and obesity: impact on cardiovascular disease and mortalityKlaus Peder Klausen, Hans-Henrik Parving, Henrik Scharling, et al.
Kidney International|January 12, 2002
Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathyHenrik P Hansen, Peter Hovind, Berit R Jensen, et al.
Diabetes Care|December 28, 2002
Autoregulation of glomerular filtration rate in patients with type 2 diabetes during isradipine therapyPer K Christensen, Kamran Akram, Karen B Kønig, et al.
Pageof 83